Discontinued — last reported Q1 '26
Verquvo — Intangible assets
Merck & Co. Verquvo — Intangible assets decreased by 7.5% to $37.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 11.9%, from $42.00M to $37.00M. Over 4 years (FY 2021 to FY 2025), Verquvo — Intangible assets shows a downward trend with a -13.1% CAGR.
Analysis
How to read this metric
A decrease typically indicates ongoing amortization or potential impairment, while an increase suggests new capital investment or acquisition of rights related to the product.
Detailed definition
This metric represents the net book value of capitalized intellectual property, patents, and acquired product rights ass...
Peer comparison
Peers in the pharmaceutical industry report similar figures under 'Intangible Assets' or 'Product Rights' within segment-level disclosures.
mrk_segment_verquvo_intangible_assetsHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $75.00M | $72.00M | $68.00M | $65.00M | $60.00M | $53.00M | $57.00M | $56.00M | $55.00M | $51.00M | $52.00M | $49.00M | $47.00M | $47.00M | $42.00M | $42.00M | $43.00M | $41.00M | $40.00M | $37.00M |
| QoQ Change | — | -4.0% | -5.6% | -4.4% | -7.7% | -11.7% | +7.5% | -1.8% | -1.8% | -7.3% | +2.0% | -5.8% | -4.1% | +0.0% | -10.6% | +0.0% | +2.4% | -4.7% | -2.4% | -7.5% |
| YoY Change | — | — | — | — | -20.0% | -26.4% | -16.2% | -13.8% | -8.3% | -3.8% | -8.8% | -12.5% | -14.5% | -7.8% | -19.2% | -14.3% | -8.5% | -12.8% | -4.8% | -11.9% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Merck & Co.'s verquvo — intangible assets?
- Merck & Co. (MRK) reported verquvo — intangible assets of $37.00M in Q1 2026.
- How has Merck & Co.'s verquvo — intangible assets changed year-over-year?
- Merck & Co.'s verquvo — intangible assets decreased by 11.9% year-over-year, from $42.00M to $37.00M.
- What is the long-term trend for Merck & Co.'s verquvo — intangible assets?
- Over 4 years (2021 to 2025), Merck & Co.'s verquvo — intangible assets has grown at a -13.1% compound annual growth rate (CAGR), from $291.00M to $166.00M.
- What does verquvo — intangible assets mean?
- The current accounting value of the patents and intellectual property rights for this specific product.